Photrexa cross-linking kit 6ML
Ended Awarded
- Contract number
- SPE2DR26FCYW3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,901
Award facts
- Contract value 100% obligated
- $16,900.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,900.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of a Photrexa Cross-Linking Kit (6ml). This firm fixed-price delivery order was awarded on November 14, 2025, with an ultimate completion date of December 8, 2025, and will be performed at the vendor's Park Ridge location. The award was issued without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement.
This delivery order is issued under DMS Pharmaceutical Group's recently awarded single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling value and extends through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to supply comprehensive pharmaceutical products and medical consumables to support Department of Defense military healthcare operations globally. As an authorized regional prime vendor contractor under this initiative, DMS Pharmaceutical Group is positioned to fulfill diverse and specialized pharmaceutical requirements across DoD healthcare facilities worldwide through firm fixed-price delivery orders for branded and generic prescription medications, biologics, vaccines, and medical supplies.
Quick answers
Who was awarded contract SPE2DR26FCYW3?
SPE2DR26FCYW3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FCYW3 worth?
The government has obligated $16,901 on SPE2DR26FCYW3.
Is contract SPE2DR26FCYW3 an order under another contract?
Yes. SPE2DR26FCYW3 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYW3 competed?
The extent of competition for SPE2DR26FCYW3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award